AVITA Medical (RCEL) Competitors $11.77 +0.29 (+2.53%) (As of 12/20/2024 05:30 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RCEL vs. ESTA, BLFS, PLSE, AORT, EMBC, CBLL, LQDA, EYE, BVS, and FNAShould you be buying AVITA Medical stock or one of its competitors? The main competitors of AVITA Medical include Establishment Labs (ESTA), BioLife Solutions (BLFS), Pulse Biosciences (PLSE), Artivion (AORT), Embecta (EMBC), CeriBell (CBLL), Liquidia (LQDA), National Vision (EYE), Bioventus (BVS), and Paragon 28 (FNA). These companies are all part of the "medical equipment" industry. AVITA Medical vs. Establishment Labs BioLife Solutions Pulse Biosciences Artivion Embecta CeriBell Liquidia National Vision Bioventus Paragon 28 AVITA Medical (NASDAQ:RCEL) and Establishment Labs (NASDAQ:ESTA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, analyst recommendations, community ranking, valuation, profitability, dividends and risk. Does the MarketBeat Community favor RCEL or ESTA? Establishment Labs received 43 more outperform votes than AVITA Medical when rated by MarketBeat users. However, 67.89% of users gave AVITA Medical an outperform vote while only 61.90% of users gave Establishment Labs an outperform vote. CompanyUnderperformOutperformAVITA MedicalOutperform Votes7467.89% Underperform Votes3532.11% Establishment LabsOutperform Votes11761.90% Underperform Votes7238.10% Which has more volatility and risk, RCEL or ESTA? AVITA Medical has a beta of 1.6, suggesting that its stock price is 60% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 1.16, suggesting that its stock price is 16% more volatile than the S&P 500. Which has preferable earnings and valuation, RCEL or ESTA? AVITA Medical has higher earnings, but lower revenue than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than AVITA Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAVITA Medical$60.04M5.14-$35.38M-$2.23-5.28Establishment Labs$153.07M7.32-$78.50M-$2.58-15.51 Is RCEL or ESTA more profitable? Establishment Labs has a net margin of -46.13% compared to AVITA Medical's net margin of -95.47%. Establishment Labs' return on equity of -184.55% beat AVITA Medical's return on equity.Company Net Margins Return on Equity Return on Assets AVITA Medical-95.47% -194.69% -60.67% Establishment Labs -46.13%-184.55%-24.81% Do analysts prefer RCEL or ESTA? AVITA Medical presently has a consensus price target of $16.50, suggesting a potential upside of 40.19%. Establishment Labs has a consensus price target of $60.60, suggesting a potential upside of 51.46%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts clearly believe Establishment Labs is more favorable than AVITA Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AVITA Medical 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00 Does the media favor RCEL or ESTA? In the previous week, AVITA Medical had 2 more articles in the media than Establishment Labs. MarketBeat recorded 4 mentions for AVITA Medical and 2 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 0.95 beat AVITA Medical's score of 0.25 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AVITA Medical 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals and insiders hold more shares of RCEL or ESTA? 27.7% of AVITA Medical shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 1.8% of AVITA Medical shares are owned by company insiders. Comparatively, 11.4% of Establishment Labs shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryEstablishment Labs beats AVITA Medical on 13 of the 19 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get AVITA Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for RCEL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCEL vs. The Competition Export to ExcelMetricAVITA MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$300.98M$4.33B$5.10B$9.07BDividend YieldN/A41.46%4.90%4.21%P/E Ratio-5.2825.3791.0817.15Price / Sales5.1445.671,113.51116.81Price / CashN/A43.4642.2637.86Price / Book6.137.364.784.78Net Income-$35.38M$13.64M$119.77M$225.60M7 Day Performance-3.60%-2.82%-1.87%-1.23%1 Month Performance-9.46%0.54%11.46%3.07%1 Year Performance-6.44%41.80%30.53%16.48% AVITA Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCELAVITA Medical1.6504 of 5 stars$11.77+2.5%$16.50+40.2%-5.3%$300.98M$60.04M-5.28130News CoveragePositive NewsESTAEstablishment Labs2.5211 of 5 stars$46.32+0.7%$60.60+30.8%+73.3%$1.30B$153.07M-17.83960Positive NewsBLFSBioLife Solutions1.2666 of 5 stars$27.20+1.9%$28.29+4.0%+79.4%$1.26B$146.96M-25.19409Analyst ForecastInsider TradeNews CoverageGap DownPLSEPulse Biosciences1.8696 of 5 stars$20.50+16.1%N/A+56.3%$1.26B$700,000.000.00140Insider TradeNews CoverageAORTArtivion2.2159 of 5 stars$29.02+0.3%$31.80+9.6%+59.5%$1.22B$384.90M-1,446.501,500Positive NewsEMBCEmbecta3.7712 of 5 stars$19.84+1.7%$23.00+15.9%+13.5%$1.15B$1.12B14.712,200Short Interest ↓CBLLCeriBellN/A$29.04-0.6%$32.60+12.3%N/A$1.04B$60.04M0.00N/ALQDALiquidia3.4225 of 5 stars$11.07+1.4%$24.00+116.8%+3.7%$936.93M$15.61M-6.7050Analyst ForecastNews CoverageEYENational Vision3.0673 of 5 stars$11.59+1.6%$14.00+20.8%-41.2%$912.71M$2.13B-57.0513,998Analyst RevisionNews CoveragePositive NewsBVSBioventus3.6174 of 5 stars$11.17+1.3%$16.00+43.2%+104.8%$906.50M$555.06M-18.081,200Analyst UpgradeGap DownFNAParagon 283.0405 of 5 stars$10.60+1.7%$15.60+47.2%-17.7%$887.43M$245.00M-14.08343,000 Related Companies and Tools Related Companies Establishment Labs Alternatives BioLife Solutions Alternatives Pulse Biosciences Alternatives Artivion Alternatives Embecta Alternatives CeriBell Alternatives Liquidia Alternatives National Vision Alternatives Bioventus Alternatives Paragon 28 Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RCEL) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVITA Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVITA Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
